BSE Live
Jun 02, 16:01Prev. Close
639.75
Open Price
641.80
Bid Price (Qty.)
632.95 (1)
Offer Price (Qty.)
641.50 (23)
NSE Live
Jun 02, 15:47Prev. Close
640.55
Open Price
634.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Quarterly Results of Eris Lifesciences (in Rs. Cr.) | Mar '23 | Dec '22 | Sep '22 | Jun '22 | Mar '22 | |
Net Sales/Income from operations | 308.36 | 326.76 | 349.98 | 322.02 | 277.12 | |
Other Operating Income | 6.23 | 5.25 | 5.39 | 6.74 | 5.02 | |
Total Income From Operations | 314.58 | 332.01 | 355.37 | 328.76 | 282.14 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | 25.07 | 25.55 | 32.91 | 30.60 | 30.01 | |
Purchase of Traded Goods | 29.68 | 20.58 | 39.84 | 23.66 | 26.90 | |
Increase/Decrease in Stocks | -6.06 | 11.93 | -2.37 | 5.00 | -7.01 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 60.63 | 61.75 | 69.18 | 61.39 | 52.65 | |
depreciat | 17.28 | 16.50 | 15.90 | 14.97 | 15.07 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 93.77 | 85.81 | 74.76 | 81.93 | 77.98 | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 94.21 | 109.89 | 125.14 | 111.22 | 86.55 | |
Other Income | 4.26 | 3.48 | 6.15 | 3.37 | 9.05 | |
P/L Before Int., Excpt. Items & Tax | 98.47 | 113.37 | 131.30 | 114.59 | 95.61 | |
Interest | 2.96 | 3.14 | 7.49 | 7.23 | 0.98 | |
P/L Before Exceptional Items & Tax | 95.51 | 110.23 | 123.81 | 107.36 | 94.63 | |
Exceptional Items | -- | -- | -- | -- | -- | |
P/L Before Tax | 95.51 | 110.23 | 123.81 | 107.36 | 94.63 | |
Tax | 7.67 | 10.85 | 8.61 | 11.77 | 7.92 | |
P/L After Tax from Ordinary Activities | 87.84 | 99.38 | 115.20 | 95.59 | 86.71 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 87.84 | 99.38 | 115.20 | 95.59 | 86.71 | |
Equity Share Capital | 13.60 | 13.60 | 13.60 | 13.60 | 13.59 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 6.46 | 7.31 | 8.47 | 7.03 | 6.38 | |
Diluted EPS | 6.43 | 7.31 | 8.46 | 7.03 | 6.38 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 6.46 | 7.31 | 8.47 | 7.03 | 6.38 | |
Diluted EPS. | 6.43 | 7.31 | 8.46 | 7.03 | 6.38 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
17.05.2023
Eris Life Standalone March 2023 Net Sales at Rs 314.58 crore, up 11.5% Y-o-Y
17.05.2023
Eris Life Consolidated March 2023 Net Sales at Rs 402.80 crore, up 31.66% Y-o-Y
20.01.2023
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y
20.01.2023
Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher